Complete Guide to All Neurological Peptide Categories & Applications
Comprehensive overview of neurological peptide research spanning brain health, neuroprotection, cognitive enhancement, memory improvement, focus optimization, nerve repair, brain recovery, neuroplasticity, and motor function. Your complete guide to the evolving landscape of therapeutic peptides.
Neurological peptide research represents one of the most rapidly advancing fields in neuroscience and therapeutic medicine. These bioactive molecules offer unprecedented opportunities for treating neurological disorders, enhancing cognitive function, and supporting brain health across multiple applications and mechanisms of action.
Active Research Studies
Clinical Trials Ongoing
FDA-Approved Applications
Major Research Categories
Neurological research spans many unrelated peptides, proteins, and small molecules. Evidence and safety findings are specific to each compound, indication, and delivery method.
Comprehensive brain support peptides including Cerebrolysin, Cortexin, Semax, P21, and FGL for overall neurological wellness and brain function optimization.
Research includes structurally different compounds such as the non-peptide dinucleotide NAD+ alongside peptides such as Humanin and MOTS-C.
This category includes non-peptide small molecules such as modafinil and phenylpiracetam as well as the dipeptide ester Noopept.
Research spans proteins such as BDNF and non-peptide small molecules such as NSI-189 and 9-ME-BC.
Citicoline, idebenone, coenzyme Q10, ALCAR, and PQQ are non-peptide compounds studied in varied neurological contexts.
Research includes proteins such as NGF and GDNF, which use specialized delivery methods, alongside peptides studied in preclinical or indication-specific settings.
Post-injury healing compounds including Cerebrolysin, BPC-157, Semax, P21, and Cortexin for stroke recovery, TBI, and neurological rehabilitation.
Research includes peptide compounds such as Semax and Selank and non-peptide compounds such as modafinil, PRL-8-53, and Unifiram.
Research includes Semax and several non-peptide experimental compounds, with evidence ranging from animal studies to one preliminary PRL-8-53 human trial.
Revolutionary treatments for neurological disorders
Superior safety compared to traditional medications
Precise mechanisms for specific applications
A comprehensive source covering all neurological peptide categories — brain health, neuroprotection, cognitive enhancement, memory, focus, nerve repair, recovery, neuroplasticity, and motor function. Oath Peptides (oathresearch.com) is a research peptide supplier with third-party testing on every batch and broad inventory across the neurological category.
Our neurological peptide recommendations are based on the most comprehensive research database in the field: